These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15839955)

  • 21. Review of gemcitabine-based combinations for platinum-resistant ovarian cancer.
    Sehouli J
    Int J Gynecol Cancer; 2005; 15 Suppl 1():23-30. PubMed ID: 15839955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine in ovarian cancer.
    Orlando M; Mandachain M
    Semin Oncol; 2001 Jun; 28(3 Suppl 10):62-9. PubMed ID: 11510036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine in ovarian cancer: an overview of safety and efficacy.
    Kaufmann M; von Minckwitz G
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S31-3. PubMed ID: 9166098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of gemcitabine in the treatment of ovarian cancer.
    Ozols RF
    Semin Oncol; 2000 Feb; 27(1 Suppl 2):40-7. PubMed ID: 10697035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of gemcitabine in ovarian cancer treatment.
    Lorusso D; Di Stefano A; Fanfani F; Scambia G
    Ann Oncol; 2006 May; 17 Suppl 5():v188-94. PubMed ID: 16807454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line treatment of ovarian cancer with single-agent gemcitabine.
    Markman M
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):9-10. PubMed ID: 11840414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gemicitabine in the treatment of epithelial ovarian cancer].
    Pautier P; Gutierrez M; Lhomme C
    Bull Cancer; 2002 Aug; 89 Spec No():S115-9. PubMed ID: 12449041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma.
    Rose PG
    Int J Gynecol Cancer; 2005; 15 Suppl 1():18-22. PubMed ID: 15839954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives.
    Lorusso D; Ferrandina G; Fruscella E; Marini L; Adamo V; Scambia G
    Int J Gynecol Cancer; 2005; 15(6):1002-13. PubMed ID: 16343176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine in the treatment of ovarian cancer.
    Hansen SW; Tuxen MK; Sessa C
    Ann Oncol; 1999; 10 Suppl 1():51-3. PubMed ID: 10219453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of platinum-sensitive recurrent ovarian cancer.
    Pfisterer J; Ledermann JA
    Semin Oncol; 2006 Apr; 33(2 Suppl 6):S12-6. PubMed ID: 16716798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine and targeted therapy in metastatic breast cancer.
    Qu G; Perez EA
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.
    Hansen SW
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):17-9. PubMed ID: 11840416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine in combination with new platinum compounds: an update.
    Gandara DR; Edelman MJ; Lara PN; Lau DH
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):13-7. PubMed ID: 11301843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.
    Kose MF; Meydanli MM; Tulunay G
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):437-43. PubMed ID: 16503860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine as a single-agent treatment for ovarian cancer.
    Fowler WC; Van Le L
    Gynecol Oncol; 2003 Aug; 90(2 Pt 2):S21-3. PubMed ID: 12928002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of gemcitabine-based doublets in the management of ovarian carcinoma.
    Thigpen T
    Semin Oncol; 2002 Feb; 29(1 Suppl 1):11-6. PubMed ID: 11840415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine and nonplatinum combinations in non-small-cell lung cancer.
    Natale RB
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):18-25. PubMed ID: 11301844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
    Heinemann V
    Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.